PROTAC BRD4 Degrader-36
PROTAC BRD4 Degrader-36 is a BRD4 PROTAC degrader with a DC50 of 0.649 nM. It has a Kd of 123 nM for TRIM21. PROTAC BRD4 Degrader-36 recruits the E3 ubiquitin ligase TRIM21 (Kd = 123 nM) to BRD4, leading to ubiquitination and subsequent degradation of BRD4. PROTAC BRD4 Degrader-36 exhibits cytotoxicity against PANC-1 cells (GI50 = 0.103 μM). It can be used in research related to pancreatic cancer.
(Pink: BRD4 ligand (HY-129939); Blue: TRIM21 E3 ligase ligand; Black: linker).
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- 화학식: C52H58F2N6O7S3
- 분자량:1013.24
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
All PROTACs Isoforms
More
Biological Activity
제품 설명
IC50 & Target
[1]|
BRD4 0.649 nM (DC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| PANC-1 | DC50 |
0.649 nM
|
BRD4 degradation in human PANC-1 cells assessed via high-content analysis (HCA) after 24 hours of incubation.
BRD4 degradation in human PANC-1 cells assessed via high-content analysis (HCA) after 24 hours of incubation.
|
40623734 |
| PANC-1 | GI50 |
0.103 μM
|
Antiproliferative activity against human PANC-1 cells assessed via antiproliferation assay.
Antiproliferative activity against human PANC-1 cells assessed via antiproliferation assay.
|
40623734 |
In Vitro
PROTAC BRD4 Degrader-36 (Compound TrimTAC-1) (0.001-10 μM; 3 days) inhibits the proliferation of PANC-1 cells, with a GI50 value of 0.103 μM[1].
PROTAC BRD4 Degrader-36 (0.01 nM-10 mM; 24 h) exerts a dose-dependent BRD4 protein degradation effect in PANC-1 cells, with a DC50 of 0.649 nM and a Dmax of 71%[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
분자량 1013.24
-
화학식 C52H58F2N6O7S3
-
SMILES
O=C(C1=C(C=C2C3=CN(C(C4=C3C(CN(C2=C1)C5=NC=C(C=C5F)F)=CN4)=O)C)CS(C)(=O)=O)NCCCCCCCN(CC6CCCCC6)C(C7=C(S(=O)(C)=O)C=C(C=C7)C8=CC=CC=C8SC)=O
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)